Fig 1.
Flowchart of patient inclusion and exclusion.
Fig 2.
Boxplot of CD4 cell counts [/μl] in patients with disseminated NTM disease (n = 37), controls before matching (n = 321) and controls after matching (n = 37).
Table 1.
General characteristics and mycobacterial species in patients with disseminated NTM disease and controls.
CD4-cell counts refer to baseline in patients with disseminated NTM disease and the nadir in controls.
Table 2.
Opportunistic infections, AIDS related malignancies, vegetative symptoms, NTM related diagnostics and complications in patients with disseminated NTM disease and controls.
Opportunistic infections or comorbidities that did neither occur in the case nor in the control group are not shown.
Table 3.
Other infections, comorbidities and behavioral risk factors in patients with disseminated NTM disease and controls.
Fig 3.
Survival analysis (A) and time to first rehospitalisation (B) in patients with disseminated NTM disease and controls.
There was a non-significant trend to higher mortality in patients with disseminated NTM disease (p = 0.24). Time to rehospitalisation was significantly shorter in those patients (p<0.001).
Table 4.
Antiretroviral and antimycobacterial treatment in the case group and controls.